Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia‐related resource use
Open Access
- 30 August 2007
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 26 (9) , 1267-1275
Abstract
Background Screening for Helicobacter pylori reduces dyspepsia and dyspepsia‐related costs in positive individuals. Aims To assess effect of knowledge of H. pylori status on healthcare‐seeking in negative individuals. Methods H. pylori‐negative subjects in a community screening programme were randomized to placebo triple therapy or informed of their negative H. pylori status. Dyspepsia‐related resource data were extracted from primary care records at 2 years, and National Health Service reference costs were applied to calculate the total cost per subject. Proportions of individuals incurring any cost were compared using a relative risk (RR) and 95% confidence interval (CI). Differences in costs were compared using an independent sample t‐test. Results A total of 1353 H. pylori‐negative individuals were randomized to placebo whilst 1355 were informed of their infection status. In the placebo arm, 212 (16%) subsequently incurred any dyspepsia‐related cost compared to 172 (13%) informed of their infection status (RR of incurring cost = 0.81; 95% CI: 0.67–0.97). Those informed of their infection status incurred lower costs (mean saving per individual = £11.02; 95% CI: −£3.52 to 25.56). Conclusions H. pylori‐negative individuals informed of infection status sought health care for dyspepsia less often than those who were unaware. Population screening may reduce dyspepsia‐related costs in uninfected, as well as infected individuals.Keywords
This publication has 26 references indexed in Scilit:
- The proportion of upper gastrointestinal symptoms in the community associated with helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugsAmerican Journal of Gastroenterology, 2000
- A prospective randomised trial of a “test and treat” policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinicGut, 1999
- Randomized controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: a cost‐effectiveness analysisAlimentary Pharmacology & Therapeutics, 1998
- Opening Pandora's box: the unpredictability of reassurance by a normal test resultBMJ, 1996
- A survey of dyspepsia in Great BritainAlimentary Pharmacology & Therapeutics, 1996
- Irritable bowel syndrome and dyspepsia in the general population: Overlap and lack of stability over timeGastroenterology, 1995
- Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsiaThe Lancet, 1994
- Dyspepsia in England and Scotland.Gut, 1990
- Prevalence of symptoms of dyspepsia in the community.BMJ, 1989
- Studies of the epidemiology of peptic ulcer in a rural community: prevalence and natural history of dyspepsia and peptic ulcer.Gut, 1968